Varia Ventures

MimiVax, LLC is a clinical-stage biotechnology company based in Buffalo, New York, that specializes in developing immunotherapeutic vaccines and targeted therapies for cancer treatment. Founded in 2011, the company focuses on harnessing survivin-targeting technology to create vaccines that address a cell-survival protein commonly found in many cancers. Its lead product, SurVaxM, is a peptide mimic immunotherapeutic vaccine designed to control tumor growth and prevent recurrence, thereby improving patient survival rates. Through its innovative approaches, MimiVax aims to provide effective treatment options for cancer patients by disrupting the mechanisms that allow tumors to thrive.

Founded in 2014, Buffalo Automation Group develops automated self-navigation technology for ships, waterways, and recreational boats. Its flagship product, AutoMate, equips existing boats with forward-facing cameras to identify obstacles and enables captains to input destinations for autonomous navigation, along with real-time weather updates.